Evidence map›Paper›PMID 40335504›Full record

ArticleCell death discovery2025

Role of ANT2 in mitochondrial function and cancer cell survival: a target for therapeutic intervention.

Klara Bohacova, Zuzana Nahacka, Jana Dudova, Jaromira Kovarova, Jakub Rohlena, Michaela Rennerova, Barbora Judita Kasperova, Jan Stursa, Lukas Werner, Martin Haluzik and 2 more

Abstract readLetter
In one paragraph

Article in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Klara BohacovaInstitute of Biotechnology, Czech Academy of Sciences, Prague-West, Czechia. klara.bohacova@ibt.cas.cz.ORCID http://orcid.org/0009-0006-3939-2349
Zuzana NahackaInstitute of Biotechnology, Czech Academy of Sciences, Prague-West, Czechia.ORCID http://orcid.org/0000-0003-0477-2764
Jana DudovaDiabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia.ORCID http://orcid.org/0009-0002-0765-2901
Jaromira KovarovaInstitute of Biotechnology, Czech Academy of Sciences, Prague-West, Czechia.
Jakub RohlenaInstitute of Biotechnology, Czech Academy of Sciences, Prague-West, Czechia.ORCID http://orcid.org/0000-0001-5427-6502
Michaela RennerovaCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czechia.
Barbora Judita KasperovaDiabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia.ORCID http://orcid.org/0000-0003-4578-1093
Jan StursaInstitute of Biotechnology, Czech Academy of Sciences, Prague-West, Czechia.
Lukas WernerInstitute of Biotechnology, Czech Academy of Sciences, Prague-West, Czechia.
Martin HaluzikDiabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia.ORCID http://orcid.org/0000-0002-0201-6888
Jiri NeuzilInstitute of Biotechnology, Czech Academy of Sciences, Prague-West, Czechia.ORCID http://orcid.org/0000-0002-2478-2460
Sona Stemberkova HubackovaInstitute of Biotechnology, Czech Academy of Sciences, Prague-West, Czechia. hubs@ikem.cz.ORCID http://orcid.org/0000-0002-3454-6840

Funding

Grantová Agentura České Republiky (Grant Agency of the Czech Republic) 24-10167SGrantová Agentura, Univerzita Karlova (Charles University Grant Agency) GA UK 1306120Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic) NU22-01-00096, NW24-06-00021
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40335504
PMCPMC12059193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.